Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.
about
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisAminoadamantanes versus other antiviral drugs for chronic hepatitis CAminoadamantanes for chronic hepatitis CAminoadamantanes versus other antiviral drugs for chronic hepatitis CAminoadamantanes for chronic hepatitis CRecent advances in managing chronic HCV infection: focus on therapy in patients with severe liver diseaseKASL clinical practice guidelines: management of hepatitis CHistorical review of the causes of cancerControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaChronic hepatitis C: This and the new era of treatmentTransient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominanceHepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?Hepatitis C cirrhosis: New perspectives for diagnosis and treatmentBurden of disease and cost of chronic hepatitis C infection in CanadaChronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysisDirect acting antivirals for the treatment of chronic viral hepatitisSustained virological response in a predominantly hepatitis C virus genotype 4 infected populationMolecular mechanism and treatment of viral hepatitis-related liver fibrosis.Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysisState of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationSASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infectionHepatitis C.Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United StatesCost-effectiveness of Telaprevir combination therapy for chronic hepatitis CWill Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World DataGlobal epidemiology and burden of HCV infection and HCV-related disease.APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis CCost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1The hepatitis C cascade of care: identifying priorities to improve clinical outcomesThe impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, VietnamCost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in IndiaUltrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UKTrends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studyUnderstanding the natural history of chronic HBV and HCV infectionsCost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals.The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis.Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus.
P2860
Q21261905-764418EE-B071-440D-8514-7DBD3B4A6955Q24193940-7F428F38-9F64-49A3-80F3-13A60B633AE7Q24194770-174E43A5-11E9-478F-B16A-1FCF85526FFDQ24194815-490D88AD-031E-4C2A-A4AA-BE8DFE058FDBQ24201226-EFB5518E-E617-4B93-81F4-41E5A47828BEQ26752433-05088F7C-18BF-46A5-A534-DCBED5ADD4F8Q26752471-74412454-C0C9-44FE-A771-E34A6EB42ABBQ26767036-CFC57747-233B-47A8-BED7-968967746AEFQ26772324-7480DEB2-D692-4091-B40B-B5718FDDFA98Q26775011-22810D5E-C2E4-446A-B9C9-D63C60E2630AQ26776180-B0AE5654-3460-4839-8E06-2CB4CF3E859FQ26777659-499B615D-B20E-43F7-8F2D-E7B248446F78Q26798469-E463E440-284E-4078-BF7A-9FD2BD564FE2Q26799924-5016E9C4-DCA8-4263-B1EC-FD82B4A3F429Q26849591-736D9809-DA49-417A-BDD1-8AC74191F093Q26991791-0C692761-372F-4EDB-B3B8-9B2FF174CD40Q27022216-6342A29A-FB9B-44A5-AE19-E4494D2EA261Q27489667-7398F169-C8AA-4646-90C7-EC86ABD7D275Q27692609-2915F2EF-20EB-4080-AB77-B2094FE1236FQ28076352-1ECC61F1-D385-4528-B365-0BCAB5CDB4E2Q28079102-BE322A27-2FF6-4E55-A0B8-7AFFBFC5B396Q28082474-7C3D83F3-97CA-4B13-84B0-D7635971E924Q28084654-458EE984-7905-4F84-89D7-412082B95AD2Q28488762-4A43A86C-0D7A-4ABB-B236-2D955DF33FE0Q28540562-16829748-D831-49F1-AE76-7BEBCC0611D9Q28550101-C0E04652-1392-4685-B0B8-E5AB1FF330B1Q30240220-F6BC9088-19A0-4CFD-8FC6-D68C5A5B648FQ30250088-4B5F8702-3339-4982-895C-83977D1693DDQ30429470-0D296F13-759A-4CBA-9489-EA833AAA03DEQ30471886-E1DB599C-A840-4108-B78C-4D3210726DB4Q33629561-9E4CE5B1-281C-4ABD-9A09-BBC4DDA9D70EQ33632459-6C62A791-C469-427A-A02B-799FC8B40F35Q33663998-14C1BF35-3261-4F28-AC4E-043AFD4F5C7DQ33698956-F727A88E-3EC8-4A49-976A-5DB4530CB33BQ33795154-A97A0C6C-57FC-42E5-84A5-4603B99E3236Q33801743-E344FD3F-4BEC-4242-B851-1DFD8D2465B3Q33817582-C0BE982C-96AC-4221-B67A-528A07A7E32FQ33831652-AEC956DD-FEE1-445D-A4E3-5B44E4DA7A4CQ33916243-E7DD7D86-2D4B-4ED2-90D9-F0C53F5D7629Q33922932-E06DE515-DA01-4CDA-AD67-7C3F58914A22
P2860
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Estimation of stage-specific f ...... -analysis and meta-regression.
@ast
Estimation of stage-specific f ...... -analysis and meta-regression.
@en
Estimation of stage-specific f ...... -analysis and meta-regression.
@nl
type
label
Estimation of stage-specific f ...... -analysis and meta-regression.
@ast
Estimation of stage-specific f ...... -analysis and meta-regression.
@en
Estimation of stage-specific f ...... -analysis and meta-regression.
@nl
prefLabel
Estimation of stage-specific f ...... -analysis and meta-regression.
@ast
Estimation of stage-specific f ...... -analysis and meta-regression.
@en
Estimation of stage-specific f ...... -analysis and meta-regression.
@nl
P2860
P356
P1433
P1476
Estimation of stage-specific f ...... -analysis and meta-regression.
@en
P2093
Gregory J Dore
P2860
P304
P356
10.1002/HEP.22375
P407
P577
2008-08-01T00:00:00Z